Petranker R

Department of Surgery, McMaster University, Hamilton, ON, Canada.

15 papers · 3 preprints · ORCID

ArticleKetamine

Real-World Therapeutic Use of Ketamine in Clinical and Non-Clinical Settings: A Cross-Sectional Survey.

Syed OA, Petranker R, Nestor SM +6

ArticlePsilocybin

Microdosing psychedelics: What, why, when, and how often? Insights from an international survey of people who use psychedelics.

Petranker R, Syed OA, Sobolenko V +5

PreprintPsilocybin

Patient perceptions towards psychedelics for musculoskeletal pain: A cross-sectional survey

Li EJ, Mosharraf B, Ali H +9

ArticlePsilocybin

Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial - CORRIGENDUM.

Beidas Z, Ragnhildstveit A, Blackman A +8

PreprintPsilocybin

Safety and Efficacy of Microdosing Psilocybin over 8 Weeks for Major Depressive Disorder: A Randomized Clinical Trial

Petranker R, Farb N, Syed O +4

ArticlePsilocybin

Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial.

Beidas Z, Ragnhildstveit A, Blackman A +9

PreprintPsilocybin

Microdosing Psilocybin for Major Depressive Disorder: Study Protocol for a Phase II Double-Blind Placebo-Controlled Randomized Partial Crossover Trial

Beidas Z, Ragnhildstveit A, Blackman A +9

ArticlePsilocybin

The effect of psychedelic microdosing on animal behavior: A review with recommendations for the field.

Syed OA, Petranker R, Tsang B

ArticlePsilocybin

Preferences, Perceptions, and Environmental Considerations of Natural and Synthetic Psychedelic Substances: Findings from the Global Psychedelic Survey.

Syed OA, Petranker R, Fewster EC +5

ArticlePsilocybin

Global Trends in Psychedelic Microdosing: Demographics, Substance Testing Behavior, and Patterns of Use.

Syed OA, Petranker R, Fewster EC +5

ArticlePsilocybin

Keeping the promise: a critique of the current state of microdosing research.

Petranker R, Anderson T, Fewster EC +4

ArticlePsychedelics

Psychedelics and neonihilism: connectedness in a meaningless world.

Plesa P, Petranker R

ArticlePsilocybin

Set and setting in microdosing: an oft-overlooked principle.

Hartogsohn I, Petranker R

ArticlePsilocybin

Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention.

Petranker R, Anderson T, Maier LJ +3

ArticlePsilocybin

Psychedelic Research and the Need for Transparency: Polishing Alice's Looking Glass.

Petranker R, Anderson T, Farb N

ArticlePsilocybin

Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities.

Rosenbaum D, Weissman C, Anderson T +4

ArticlePsilocybin

Psychedelic microdosing benefits and challenges: an empirical codebook.

Anderson T, Petranker R, Christopher A +5

ArticlePsilocybin

Microdosing psychedelics: personality, mental health, and creativity differences in microdosers.

Anderson T, Petranker R, Rosenbaum D +5